Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40368 | 0.80 | CYP2C9 (0.55) | CYP2C9LMNAMEN1KMT2AMAPT | |
| SCHEMBL5808750 | 0.79 | MAOA (0.42) | CYP2C9LMNAMEN1KMT2AMAPT | |
| SCHEMBL8492933 | 0.77 | MAOA (0.44) | CYP2C9LMNAMEN1KMT2AMAPT | |
| SCHEMBL521774 | 0.76 | MAOA (0.62) | CYP2C9LMNAMEN1KMT2AMAPT | |
| SCHEMBL215606 | 0.74 | LMNA (0.39) | LMNAMAPTMAPK1ALDH1A1 | |
| SCHEMBL2716093 | 0.70 | CYP2C9 (0.35) | CYP2C9LMNAMEN1KMT2AMAPT | |
| SCHEMBL292551 | 0.70 | GRM1 (0.32) | — | |
| SCHEMBL501810 | 0.69 | GAA (0.65) | CYP2C9LMNAMEN1KMT2AMAPT | |
| Phosphine SCHEMBL23295992 | 0.68 | GAA (0.63) | CYP2C9LMNAMEN1KMT2AMAPT | |
| SCHEMBL11781441 | 0.68 | CYP2C9 (0.44) | CYP2C9LMNAMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11932666-B2 | Polymerizable compound, compound, and method for producing boranophosphate oligomer | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2024-03-19 | — | — | US | claimed |
| US-11897977-B2 | Photolabile barbiturate compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-02-13 | — | — | US | claimed |
| US-20230108357-A1 | Polymerizable Compound, Compound, and Method for Producing Boranophosphate Oligomer | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2023-04-06 | — | — | US | claimed |
| US-20220411790-A1 | A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY | THE JOHNS HOPKINS UNIVERSITY | 2022-12-29 | — | — | US | claimed |
| US-11370940-B2 | Adhesive article and methods of making and using the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-28 | — | — | US | claimed |
| CN-109937206-B | Polymerizable compound, and method for producing borane phosphate oligomer | 学校法人东京理科大学 | 2022-04-01 | — | — | CN | claimed |
| EP-3746489-B1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M INNOVATIVE PROPERTIES CO (US) | 2022-03-30 | — | — | EP | claimed |
| US-20210277283-A1 | ADHESIVE ARTICLE AND METHODS OF MAKING AND USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-09-09 | — | — | US | claimed |
| CN-108348403-B | Redox polymerizable compositions containing photolabile transition metal complexes | 3M创新有限公司 | 2021-06-18 | — | — | CN | claimed |
| CN-108348404-B | Redox polymerizable dental compositions utilizing photolabile transition metal complexes | 3M创新有限公司 | 2021-06-08 | — | — | CN | claimed |
| US-20090131682-A1 | SUPPORTS FOR OLIGOMER SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 2009-05-21 | — | — | US | claimed |
| US-20090093618-A1 | STREPTAVIDIN-BIOTIN-LINK ANTIBODY-HAPTEN SYSTEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNA (US) | 2009-04-09 | — | — | US | claimed |
| WO-2007131242-A2 | STREPTAVIDIN-BIOTIN-LINK ANTIBODY-HAPTEN SYSTEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-11-15 | — | — | WO | claimed |
| EP-0270651-B1 | NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES | CALIFORNIA INST OF TECHN (US) | 1994-06-15 | — | — | EP | claimed |
| US-5204456-A | Derivatives of nucleosides and their use for the synthesis of oligonucleotides | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1993-04-20 | — | — | US | claimed |
| EP-0241363-B1 | NUCLEOSIDE DERIVATIVES AND THEIR USE IN THE SYNTHESIS OF OLIGONUCLEOTIDES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1991-09-25 | — | — | EP | claimed |
| US-4849513-A | Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1989-07-18 | — | — | US | claimed |
| EP-0270651-A4 | NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES. | CALIFORNIA INST OF TECHN (US) | 1989-03-29 | — | — | EP | claimed |
| EP-0270651-A1 | NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES. | CALIFORNIA INST OF TECHN (US) | 1988-06-15 | — | — | EP | claimed |
| WO-1988000201-A1 | NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY, INC. (US) | 1988-01-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11932666-B2 | Polymerizable compound, compound, and method for producing boranophosphate oligomer | NR0B2, NR2E1, NR0B1 | CYP2C9 4144/4885LMNA 869/4885MEN1 655/4885 |
| US-20090093618-A1 | STREPTAVIDIN-BIOTIN-LINK ANTIBODY-HAPTEN SYSTEM | BTD, HLCS, SSB | CYP2C9 4843/4885LMNA 3371/4885MEN1 1116/4885 |
| US-20090131682-A1 | SUPPORTS FOR OLIGOMER SYNTHESIS | ILK, NOP2, PFAS | CYP2C9 3845/4885LMNA 1785/4885MEN1 1388/4885 |
| US-11897977-B2 | Photolabile barbiturate compounds | PPOX, CBR1, CBR3 | CYP2C9 265/4885LMNA 3594/4885MEN1 4096/4885 |
| US-20230108357-A1 | Polymerizable Compound, Compound, and Method for Producing Boranophosphate Oligomer | NR0B2, NR2E1, NR0B1 | CYP2C9 4144/4885LMNA 869/4885MEN1 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.